⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LGND News
Ligand Pharmaceuticals Inc.
Form 8-K
sec.gov
LGNXZ
LGND
LGNYZ
LGNDZ
LGNZZ
Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031
globenewswire.com
LGND
Ligand Announces 2026 Investor Day in New York City
globenewswire.com
LGND
Form 8-K
sec.gov
LGND
LGNYZ
LGNZZ
LGNDZ
LGNXZ
Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development
globenewswire.com
LGND
Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development
globenewswire.com
LGND
Ligand to Participate in June Investor Conferences
globenewswire.com
LGND
Form 8-K
sec.gov
LGNXZ
LGNZZ
LGND
LGNDZ
LGNYZ
Form 8-K
sec.gov
LGNYZ
LGNXZ
LGNZZ
LGND
LGNDZ
Ligand Reports First Quarter 2026 Financial Results
globenewswire.com
LGND
XOMA
MRK
SNDX
AGEN